## Mechanistic Overview
PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction starts from the claim that modulating PLCG2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction Mechanism of Action Phospholipase C Gamma 2 represents a pivotal enzymatic node in microglial signal transduction
The ad_genetic_risk_loci dataset identifies PLCG2 rs72824905 as a rare protective AD variant with a strong protective odds-ratio proxy. The notebook's Enrichr and GTEx analysis places PLCG2 in a microglial immune signaling module with actionable phospholipase biology. Hypothesis: partial, pathway-biased PLCG2 activation can increase microglial plaque and debris clearance while avoiding broad inflammatory gain-of-function toxicity.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
PLCG2Microglial ImmunityNeuroinflammation
Convergent signals
PLCG2 recurs across 2 selected hypotheses with aligned directionality in microglial immunity, neuroinflammation.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
4/11
dimensions won
PLCG2 Allosteric Modulation as a Precisi
7/11
dimensions won
Calibrated PLCG2 activation can reproduc
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.65
0.70
Evidence
0.50
0.66
Novelty
0.70
0.64
Feasibility
0.40
0.58
Impact
0.65
0.72
Druggability
0.40
0.76
Safety
0.45
0.46
Competition
0.60
0.00
Data
0.55
0.78
Reproducible
0.70
0.62
KG Connect
0.66
0.50
Score Breakdown
Dimension
PLCG2 Allosteric Modulation as
Calibrated PLCG2 activation ca
Mechanistic
0.650
0.700
Evidence
0.500
0.660
Novelty
0.700
0.640
Feasibility
0.400
0.580
Impact
0.650
0.720
Druggability
0.400
0.760
Safety
0.450
0.460
Competition
0.600
0.000
Data
0.550
0.780
Reproducible
0.700
0.620
KG Connect
0.659
0.500
Evidence
PLCG2 Allosteric Modulation as a Precision Therapeutic for T
No evidence citations yet
Calibrated PLCG2 activation can reproduce the protective rs7
No evidence citations yet
Debate Excerpts
PLCG2 Allosteric Modulation as a Precision Therape